LEP and metabolic disease: Next, we substituted individual measurements of leptin and ADIPOQ with their ratio based on compelling evidence that this ratio serves as a promising biomarker not only for metabolic disorders and low-grade inflammation but also for assessing endometrial receptivity [21].